BioSpace News Archive

HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced that the Sarah Cannon Cancer Institute (SCCI) of HCA Healthcare has successfully established an integrated management process that safely transitioned more than 75% of HCA Healthcare’s CAR T-cell therapy patients into an outpatient setting for monitoring.

YS Biopharma Co., Ltd. (Nasdaq: YS) (“YS Biopharma” or the “Company”) today announced the results of its extraordinary general meeting (the “EGM”) held on February 22, 2024 in Hong Kong.

CTI Clinical Trials and Consulting, a full-service global research provider, is thrilled to announce that our North American laboratory facility has been granted the prestigious College of American Pathologists

The investigational medicinal product consisted of an autologous CD19 CAR T-cell therapy that was locally manufactured in the certified GMP laboratory of the Universitätsklinikum Erlangen in Erlangen, Germany.

AbCellera announced that executives from the Company will present at the following investor conferences.

Artiva Biotherapeutics, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Artiva’s lead program AlloNK®.

Twist Bioscience Corporation today announced that its executives will participate in fireside chats at the following upcoming investor conferences.

Agile Therapeutics, Inc. today announced the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 3,892,572 shares of common stock of the Company originally issued in July 2022 and May 2023, having an exercise price of $3.69 per share, at a reduced exercise price of $1.25 per share.

NeoChord is a privately held, medical technology company and the world-leader in beating heart delivery of artificial chords in the treatment of mitral valve regurgitation.

BostonGene Appoints Joe Lennerz, MD, PhD, as Chief Scientific Officer, Mark Hiatt, MD, MBA, MS as Senior Vice President of Market Access and Strategy and Ned Segal as Board Member.